TY  - JOUR

T1  - The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)ethyl-bisphosphonate), with reduced bone affinity, which is as effective as zoledronate in the treatment of myeloma bone disease in JJN3-NOD/SCID-[gamma] mice

JO  - Bone Abstracts

PY  - 2016/04/21

AU  - Lawson M

AU  - Chantry A

AU  - Paton-Hough J

AU  - Evans H

AU  - Lath D

AU  - Tsoumpra M

AU  - Lundy M

AU  - Dobson R

AU  - Quijano M

AU  - Kwaasi A

AU  - Dunford J et al

ED  - 

DO  - DOI: 10.1530/boneabs.5.p128

Y2  - 2024/12/22

ER  -